TTI-101
TVD-101-003P
Phase 2 small_molecule completed
Quick answer
TTI-101 for Idiopathic Pulmonary Fibrosis is a Phase 2 program (small_molecule) at Tvardi Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Tvardi Therapeutics
- Indication
- Idiopathic Pulmonary Fibrosis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed